Clinical trial · Observational
General Tissue Response Classification System After Chemotherapy
The Establishment of General Tissue Response Classification System After Chemotherapy According to Gastric Cancer Patients With Neoadjuvant Chemotherapy
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This research intend to collect the information of gastric cancer patients who received preoperative neoadjuvant chemotherapy and radical gastric ectomy at Department of Gastrointestinal Surgery, West China Hospital, Sichuan University. Base on The degree of edema, intraoperative effusion, fibrosis of connecting tissues, the investigators aim to constitute the core parameters of the tissue response grading system following neoadjuvant chemotherapy, and explore the mutual effect among the tissue response grading system, tumor regression response and long-term survival outcome of tumor patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Stomach Adenocarcinoma | Gastric Adenocarcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Gastric cancer surgery | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Group A
- description
- Gastric Cancer Patients who underwent Chemotherapy and will have gastric cancer surgery.
- interventionNames
- Procedure: Gastric cancer surgery
Primary outcomes (1)
- measure
- General observation of tissue fibrosis, edema and exudation (Intraoperation)
- timeFrame
- The 1 day of surgery
- description
- To assess the degree of fibrosis, edema and exudation in tumor tissue and main perigastric lymph node area during the operation.
Secondary outcomes (6)
- measure
- General observation of tissue edema (Intraoperation)
- timeFrame
- The 1 day of surgery
- description
- To assess the degree of edema in tumor tissue and main perigastric lymph node area during the operation.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: 1. The diagnosis of gastric cancer was clear,Patients with definitely clinical evidence of locally advanced disease (cT3 ⁄ 4、N-/+、M0). 2. Preoperative chemotherapy has been administered,and intended to receive surgical resection. 3. Age:less than or equal to 75 years old and more than 18 years old; 4. Without any other malignant tumor, without any serious concomitant disease. 5. Eastern Cooperative Oncology Group (ECOG) physical status score \<2, America Society of Anesthesiologist (ASA) score\<3 6. No restriction on gender or race; Informed consent has been signed by patient or entrusted agent; Exclusion Criteria: 1. Previous history of gastric ulcer or gastric perforation; 2. Previous operation history at upper abdominal, except laparoscopic cholecystectomy; 3. Emergency operation caused by obstruction, perforation,and acute hemorrhage; 4. The patient can not tolerate the surgical treatment which caused by other serious concomitant disease, such as severe pulmonary disease, cardiac clinical function below are below level 2, pulmonary infection, moderate or severe chronic obstructive pulmonary disease (COPD), chronic bronchitis 5. Patient has severe mental illness 6. The patient and agent request to withdraw from the clinical study after signing the consent form.
References
Publications (1)
- DERIVEDYang H, Zhang WH, Ge R, Peng BQ, Chen XZ, Yang K, Liu K, Chen XL, He D, Liu JP, Zhang WW, Qin Y, Zhou ZG, Hu JK. Application of Gross Tissue Response System in Gastric Cancer After Neoadjuvant Chemotherapy: A Primary Report of a Prospective Cohort Study. Front Oncol. 2021 Nov 24;11:585006. doi: 10.3389/fonc.2021.585006. eCollection 2021. PMID 34900661